ArticleCancer immunology, immunotherapy : CII2018

Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression.

Albert T Gacerez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.